Human type II low-affinity receptor for immunoglobulin G (FcgRII) constitutes a clustered gene family consisting of FcgRIIA, IIB and IIC genes. FcgRIIB is unique in its ability to transmit inhibitory signals in B cells via immunoreceptor tyrosine-based inhibitory motif (ITIM). B-cell activation and subsequent elevated production of IgG are the immunopathological features of inflammatory disease such as periodontitis. To determine whether an association with periodontitis susceptibility exists, genetic polymorphisms of FcgRIIB were examined in Japanese patients with aggressive periodontitis (AGP) and chronic periodontitis (CP), and in the race-matched healthy controls (HCs). A significant difference was observed in the distribution of FcgRIIBÀ232I/T allele (exon 5) between the AGP and HC groups, with enrichment of the 232T in the AGP group (P¼0.006). In addition, the FcgRIIB-nt 646À184A/G allele (intron 4) distribution was significantly different between the CP and HC groups, with enrichment of the nt 646À184A in the CP group (P¼0.011). These results document the association of FcgRIIB gene polymorphisms with susceptibility to periodontitis in the Japanese.
Introduction
Human type II low-affinity receptor for immunoglobulin G (FcgRII: CD32) is encoded by three highly homologous genes FcgRIIA, FcgRIIB and FcgRIIC clustered on chromosome 1q23. 1, 2 FcgRIIa and FcgRIIc contain an activatory signal motif, immunoreceptor tyrosine-based activation motif (ITAM), on their cytoplasmic tails. On the other hand, FcgRIIb contains a unique immunoreceptor tyrosine-based inhibitory motif (ITIM), and has the ability to transmit inhibitory signals in B cells. 3 Three transcripts (FcgRIIb1, FcgRIIb2 and FcgRIIb3) have been identified in FcgRIIB due to alternative mRNA splicing. FcgRIIb1 is exclusively expressed on B cells, and has complete domains from all exons. In addition, FcgRIIb1 has been shown to act as a negative feedback regulator by inhibiting B-cell antigen receptor (BCR)-elicited activation signals via ITIM through IgG immune complexes (ICs). 4, 5 Since no domain is encoded by the first intracytoplasmic exon, 6 FcgRIIb2 can internalize bound IgG ICs for antigen presentation mainly in phagocytes. 4 A soluble FcgRIIb3 encoded by a transmembrane-deleted FcgRIIb2 mRNA was identified in the macrophage supernatant. 7 Deficiency for FcgRIIb in mice was recently shown to be associated with ICs-triggered inflammation. 8, 9 Periodontitis is an infectious disease resulting from the direct effects of periodontopathic bacteria, along with the specific host immune response. Owing to its heterogeneity, periodontitis is currently classified into two broad categories, aggressive periodontitis (AGP) and chronic periodontitis (CP). 10 AGP is a high-risk periodontal disease characterized by rapid and severe periodontal tissue destruction. On the other hand, CP is most prevalent in adults, and shows slow to moderate rate of disease progression. Although periodontopathic bacteria are required for the initiation of periodontitis, interindividual differences in the disease susceptibility may be associated with genetically determined variance in host immune responses. 11, 12 Periodontitis lesions contain large numbers of lymphocytes and plasma cells. 13 Localization of CD19 þ B lymphocytes bearing FcgRII has been observed in the gingival tissue of the periodontitis patients. 14 Additionally, elevated IgG responses against periodontopathic bacteria have been observed in the gingival tissue and gingival crevicular fluid. 15, 16 Human FcgRIIB gene polymorphisms that have recently been identified may be a candidate susceptibility factor for periodontitis. 17, 18 In this study, we evaluated the relevance of FcgRIIB gene polymorphisms to susceptibility to AGP and CP.
Results

Determination of FccRIIB genotypes
In all, 11 single-nucleotide polymorphisms (SNPs) were detected in Japanese subjects, all of which were confirmed to be FcgRIIB-specific. Of these SNPs, three and one SNPs resulted in amino-acid substitutions in exon 4 (Thr 203-Met, Tyr 205-Phe, Ser 207-Ala) and exon 5 (Ile 232-Thr), respectively ( Table 1) . The other five SNPs were detected in introns 4 and 5, leading to no amino-acid substitution ( Table 2) .
Distribution of FccRIIB genotypes and alleles in AGP, CP and healthy controls
We examined whether FcgRIIB gene variation is associated with susceptibility to periodontitis, using casecontrol association analyses. Genotype frequencies of FcgRIIB did not deviate from Hardy-Weinberg equilibrium.
As shown in Table 1 , a significant over-representation of the FcgRIIB-232T (nt 695C) allele was observed in the AGP group, as compared to the CP and healthy control (HC) groups (AGP When two-locus linkage disequilibrium analyses were performed among 11 SNPs in the FcgRIIB gene in controls, we found a significant association between the nt 645 þ 7A/C (intron 4) and nt 645 þ 26G/A (intron 4), and between the nt 695T/C (exon 5) and nt 646À86C/T (intron 4) (P¼0.001 and 0.0028, respectively).
Since smoking has been shown as a risk factor for periodontitis, 19, 20 we evaluated the distributions of FcgRIIB genotypes and alleles in nonsmoker patients and controls as well (n¼23 for AGP, n¼62 for CP, n¼51 for HC). A significant over-representation of FcgRIIBÀ232T allele was observed in nonsmoker AGP patients as compared to nonsmoker CP patients (P¼0.043). The nt 646À184A allele frequency was significantly different between nonsmoker CP and HC groups (P¼0.014).
FccRIIA, IIIA and IIIB genotyping To examine whether other FcgR genes are associated with susceptibility to periodontitis, the genotypes of Values represent the number (%) of subjects in allele distribution. Linkage disequilibrium with FccRIIA, IIIA and IIIB Two-locus linkage disequilibrium analyses were conducted between the FcgRIIB polymorphisms (À232I/T and -nt 646À184A/G) and other three FcgR polymorphisms (FcgRIIAÀ131R/H, IIIAÀ158V/F and IIIBÀNA1/NA2) in controls. As shown in Table 4 , we found a weak but significant positive linkage disequilibrium between FcgRIIBÀ232I/T and FcgRIIIBÀNA1/ NA2 polymorphisms. The FcgRIIB-nt 646À184A/G was shown to have no association with other FcgR polymorphisms.
Contributions of FccRIIB and FccRIIIB loci in AGP susceptibility
To dissect the contributions of the FcgRIIBÀ232I/T and FcgRIIIBÀNA1/NA2 genotypes in AGP susceptibility, two-locus analysis was performed as shown in Table 5 . The OR of the combined FcgRIIBÀ232T and FcgRIIIBÀNA2 carrier against the combined noncarrier was calculated. We found a significant increased OR in the combined FcgRIIBÀ232T and FcgRIIIBÀNA2 carrier compared to the combined noncarrier (OR 9.50, P¼0.005).
Discussion
The genetically determined polymorphism of FcgRIIB may contribute to interindividual differences in susceptibility to inflammatory diseases such as periodontitis. In this study, we demonstrated the association of FcgRIIB gene polymorphisms with periodontitis susceptibility in the Japanese population. This is the first study demonstrating the role of FcgRIIB gene polymorphisms as a susceptibility factor for periodontitis.
FcgRIIBÀ232T allele was distributed in AGP patients more frequently than in CP patients and controls, suggesting the 232T allele to be associated with FccRIIB polymorphisms and periodontitis K Yasuda et al susceptibility to AGP. FcgRIIIB-NA2 allele was also associated with the onset of AGP, which is consistent with our previous results. 21 The haplotype formed by FcgRIIBÀ232T and FcgRIIIB-NA2 did not exist in controls, suggesting a weak but significant positive linkage disequilibrium between FcgRIIBÀ232I and FcgRIIIB-NA2, whereas 232I-NA1 was the most common haplotype in controls and patients. Additionally, in AGP patients, the FcgRIIBÀ232T allele formed a haplotype with the FcgRIIIB-NA2 allele (the estimated haplotype frequency of the 232T-NA2 was 14.8%). Furthermore, we found a strong association between the composite genotype (FcgRIIBÀ232T plus FcgRIIIB-NA2) and AGP susceptibility.
FcgRIIIB-NA2 neutrophils have been shown to exhibit less efficiency in the phagocytosis level as compared to FcgRIIIB-NA1 neutrophils. 22 However, the functional difference between the homozygous for the FcgRIIBÀ232I and T allele still remains unclear. FcgRIIb1 plays a role as a negative regulator of B cells. 23 A recent report indicated the transmembrane domain of FcgRIIb1 to be essential in inducing B-cell apoptosis. 24 It would thus be conceivable that the 232I/T polymorphism leads to hyperactivated B cells by decreased function of FcgRIIb1, contributing to the onset of AGP. Additionally, the 232I/T allele may link to the function of ITAMbearing FcgR expressed in phagocytes, as an alternative possibility. An in vitro study demonstrated FcgRIIb2 to inhibit FcgRI-mediated phagocytosis when coaggregated with FcgRI. 25 Our recent study indicated the upregulation of phagocyte FcgRI expression to be observed in periodontal lesions. 26 Furthermore, injection of intravenous gamma globulin was found to induce FcgRIIb expression, leading to inhibition of phagocytic function mediated through activating FcgR. 27 Therefore, the 232I/ T allele may alter phagocytic activity in activating FcgRbearing phagocytes in the periodontal tissue or gingival crevicular fluid.
The distribution of FcgRIIB-nt 646À184A/G polymorphism was different between CP and HC. The FcgRIIB-nt 646À184A allele was over-represented in CP patients. FcgRIIIAÀ158V and FcgRIIIB-NA2 were recently shown as a severity factor for CP. 28 In this study, we found no linkage disequilibrium between FcgRIIB-nt 646À184A/G and other FcgRIIA, IIIA and IIIB polymorphisms. These results suggested the FcgRIIB-nt 646À184A/G genotype to be a susceptibility factor for CP. This polymorphism is a silent mutation within intron 4, and may influence mRNA splicing. Therefore, it would be necessary to determine the sequence of cDNA for FcgRIIB.
Since smoking is associated with periodontitis risk, 19, 20 we further evaluated FcgRIIB genotype distribution in nonsmokers, to exclude the possible confounding effect of smoking. The over-representation of the FcgRIIBÀ232T and nt 646À184A allele was observed in AGP and CP patients, respectively. These results further underline the role of FcgRIIB gene polymorphisms as a susceptibility factor for periodontitis.
There are some limitations in the statistical significance in this case-control study. We could not find the statistical association of FcgRIIB gene polymorphisms with periodontitis susceptibility following multiple comparison tests with Bonferroni's correction (level of significance: Po0.0036), although a trend towards higher frequencies of FcgRIIBÀ232T and -nt 646À184A allele exists in AGP and CP patients, respectively. It would therefore be effective to clarify the contribution of the FcgRIIB gene polymorphisms to susceptibility to AGP and CP, with a larger number of patients and controls.
In summary, our results document FcgRIIB gene polymorphisms to be associated with susceptibility to periodontitis in Japanese populations. Identification of specific genetic susceptibility factors that are important in susceptibility to periodontitis will aid in the development of more satisfactory classification systems, diagnosis and therapeutic strategies. Further genetic studies in different ethnic populations, as well as functional analyses of FcgRIIB genotypes should be undertaken to confirm and extend our observations.
Materials and methods
Subjects
Peripheral blood (PB) samples were obtained from 32 Japanese patients with AGP (9 males and 23 females; age range 17-48 years; mean age 32 years), 72 Japanese patients with CP (19 males and 53 females; age range 36-71 years; mean age 50 years), referred to the Periodontal Clinic of the Niigata University Dental Hospital, and 72 with the race-matched HCs (42 males and 30 females; age range 23-45 years; mean age 26 years). Informed consent was obtained from all participants, with the signed format that was previously reviewed and approved by the Ethical Committee for the use of Human subjects in research, Niigata University Faculty of Dentistry. None of the participants had a history or current signs of systemic disease. 
Clinical assessments
The following clinical periodontal parameters were evaluated in all patients at the first visit by several periodontists: (1) number of missing teeth; (2) probing depth (PD), which was expressed as the mean distance from the free gingival margin to the bottom of the pockets; (3) clinical attachment level (CAL), which was expressed as the mean distance from the cement-enamel junction (CEJ) to the bottom of the pocket similarly as with PD. PD and CAL were assessed using a Williams probe at six sites around each tooth: mesiobuccal, midbuccal, disto-buccal, mesio-lingual, mid-lingual and disto-lingual locations. Measurements were recorded to the nearest millimeter. Alveolar bone loss (BL) was measured from the CEJ to the root apex at an arbitrary point on a full-mouth radiograph taken at the first visit, and expressed as a percentage of the total root length by the method of Schei et al. 29 Based on clinical and radiographic data, the patients were classified as AGP and CP, according to the classification criteria described by the American Academy of Periodontology. 10 Briefly, we defined AGP on the basis of disease onset before 35 years of age, with rapid attachment loss and bone destruction. CP patients were identified if there was evidence that the disease onset occurred after 35 years age, and that the disease progression was at a slow to moderate rate. Subjects who showed neither CAL nor PD greater than 3 mm at more than one site were classified as HC. Smoking status in patients and controls was classified as either smoker or nonsmoker, according to a standard questionnaire.
Determination of FccRIIB genotypes
Our previous study indicated five and two SNPs to be found in exon 4 and intron 4 of FcgRIIB, respectively. 17 Another recent study demonstrated one SNP to result in amino-acid substitution in exon 5. 18 Therefore, we focused on FcgRIIB exon 4 and 5, and their flanking regions as a candidate region associated with periodontitis susceptibility.
Genomic DNA was isolated from PB (Easy-DNAt Kit; Invitrogen, San Diego, CA, USA). Isolated DNA was stored at 41C until genotyping was performed. FcgRIIB-PCR and FcgRIIB-exon 4-PCR were performed as previously described. 17 Briefly, we first performed FcgRIIB-specific PCR with primer set on introns 3 and 6 ( Figure 2 ; primer pair 1), because FcgRIIC gene shows a high similarity with FcgRIIb. After the purification of the FcgRIIB-specific fragment (5057 bp), PCR with primers specific for exons 4 and 5 ( Figure 2 ; primer pairs 2 and 3) was performed next using the purified fragment as a template. FcgRIIB-exon 5-PCR was performed in a 25 ml reaction mixture containing 0.5 U Ex Taqt, and 30 ng of the purified PCR products was denatured for 10 min before 40 cycles of amplification (951C for 15 s, 591C for 30 s and 721C for 30 s) and followed by a final extension at 721C for 5 min. Nucleotide sequences of these amplified fragments were determined with the ABI PRISM Big Dye Terminator Cycle Sequencing Kit s and ABI PRISM 377 DNA sequencer.
Determination of FccRIIA, FccRIIIA and FccRIIIB genotypes FcgR genotypes for three bi-allelic polymorphisms (FcgRIIAÀ131R/H, FcgRIIIAÀ158V/F, FcgRIIIB-NA1/ NA2) were determined by means of allele-specific polymerase chain reactions, as previously described. 21 
Statistical analysis w
2 tests were used to analyze the association of the 11 FcgRIIB, FcgRIIA, FcgRIIIA and FcgRIIIB polymorphisms with susceptibility to AGP and CP. When sample numbers were small, Fisher's exact probability tests were used. Haplotype frequencies and linkage disequilibrium parameters were estimated from typing results Figure 2 Primers used in this study. *The sequences are according to M90730, M90731, M90732, M90738, NM_004001, L08108, L08109, AL359541 and AC021370. (a) The FcgRIIB exons encode two signal peptides (L1 and L2), two Ig-like domains (EC1 and EC2), a transmembrane region (TM) and cytoplasmic domains (IC1, IC2 and IC3). (b) In this procedure, three pairs of primers were used. FcgRIIB-PCR and FcgRIIB-exon 4-PCR were performed as previously described. 17 FcgRIIB-exon 5-PCR was performed in a 25 ml reaction mixture containing 0.5 U Ex Taqt and 30 ng of the purified PCR products. using the SNPAlyze s v2.2 (Dynacom Co., Ltd, Yokohama, Japan). Significance was accepted at Po0.05.
